LM, Z., AD, S., Y, Y., ZL, L., XQ, H., LZ, S., . . . ZL, Z. (2023). Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma. Frontiers in oncology, 13, 1140103. https://doi.org/10.3389/fonc.2023.1140103
Chicago Style (17th ed.) CitationLM, Zhao, Shi AD, Yang Y, Liu ZL, Hu XQ, Shu LZ, Tang YC, and Zhang ZL. "Advances in Molecular and Cell Therapy for Immunotherapy of Cholangiocarcinoma." Frontiers in Oncology 13 (2023): 1140103. https://doi.org/10.3389/fonc.2023.1140103.
MLA (9th ed.) CitationLM, Zhao, et al. "Advances in Molecular and Cell Therapy for Immunotherapy of Cholangiocarcinoma." Frontiers in Oncology, vol. 13, 2023, p. 1140103, https://doi.org/10.3389/fonc.2023.1140103.
Warning: These citations may not always be 100% accurate.